This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van den Hazel, S. J.
Right arrow Articles by van Leeuwen, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van den Hazel, S. J.
Right arrow Articles by van Leeuwen, D. J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 11 1996, 2658-2660, Vol 40, No. 11
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract

SJ van den Hazel, XH de Vries, P Speelman, J Dankert, GN Tytgat, K Huibregtse and DJ van Leeuwen
Department of Gastroenterology and Hepatology, University of Amsterdam, The Netherlands.

Biliary excretion of ciprofloxacin and piperacillin was determined in cholestatic patients who had undergone endoscopic cholangiography. The median concentration of ciprofloxacin (n = 9) was 2.36 micrograms/ml (range, 0.29 to 19.8 micrograms/ml) in bile compared with 1.66 micrograms/ml (range, 0.73 to 2.69 micrograms/ml) in serum. The median concentration of piperacillin (n = 7) was < 5 micrograms/ml (range, < 5 to 26) in bile compared with 14.3 micrograms/ml (range, 5.3 to 80) in serum. Ciprofloxacin, but not piperacillin, can be actively excreted into bile in the presence of a biliary tract obstruction.


This article has been cited by other articles:

  • Schlieman, M. G., Ho, H. S., Bold, R. J. (2003). Utility of Tumor Markers in Determining Resectability of Pancreatic Cancer. Arch Surg 138: 951-956 [Abstract] [Full Text]